A bullish divergence on RSI (Relative Strength Index) also favours the upside momentum along with MACD (Moving Average Convergence Divergence), which is in a positive crossover rising towards zero line. The support comes at 8,000 levels with an immediate resistance of 8,300 levels, which also is the 100-day moving average (DMA).
Sun Pharmaceutical Industries (SUNPHARMA): A gap-up close today may suggest a breakout on 'double bottom' formation, as per the daily chart pattern. There is no doubt that the major technical indicators RSI and MACD are signalling an upside, a strong close with a significant rise in volumes may lead to Rs 430 initially and then to Rs 460, which is its 200 DMA. The overall trend indicates a limited downside whereas the upside potential is high over the medium-term. Any correction should eventually see buying opportunities emerge. CLICK HERE FOR DETAILED CHART VIEW
ALSO READ: Five reasons why Morgan Stanley has turned bullish on Sun Pharma
Divi's Laboratories (DIVISLAB): This is one of the stocks that have not seen much weakness in the Nifty Pharma index. As the chart shows, 200 DMA is strongly acting as a support for the positive trend, which is currently placed at Rs 1,550 levels. The 100 DMA is placed at Rs 1,644 levels, which is also acting as a strong resistance. In case the counter manages to conquer this, a breakout may lead to Rs 1,730 and Rs 1,780 levels going ahead. The MACD has crossed zero line upward indicating a positive bias for the stock. CLICK HERE FOR DETAILED CHART VIEW
Piramal Enterprises(PEL): The stock is currently trading in a tight range of Rs 1,900 – Rs 2,100. This co-insides with 50 DMA placed at Rs 2,071 levels. Only a breakout above Rs 2,100 may take this counter to Rs 2,260 – Rs 2,300. RSI and MACD, which are trading in positive crossovers, also support this move. The overall scenario looks bullish, as the stock is continuously making an effort to climb Rs 2,100 levels. CLICK HERE FOR DETAILED CHART VIEW
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in